Biopsy Needle Comprehensive Study by Application (Tumor, Infection, Inflammation, Others), Working (Fully Automatic, Semi-Automatic), Utility (Disposable Needle, Non Disposable Needle), End User (Hospitals, Clinics, Ambulatory Surgical Centers) Players and Region - Global Market Outlook to 2027

Biopsy Needle Market by XX Submarkets | Forecast Years 2022-2027  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Market Overview:
Biopsy needle can be defined as a medical instrument used to perform a biopsy, which is a procedure to obtain a sample of cells from your body for laboratory testing. Common needle biopsy procedures include fine-needle aspiration and core needle biopsy. Needle biopsy may be used to take tissue or fluid samples from muscles, bones, and other organs, such as the liver or lungs. Globally, increasing prevalence of cancer and increasing healthcare spending are expected to drive the demand for biopsy needles during the period of study



AttributesDetails
Study Period2017-2027
Base Year2021
Forecast Period2022-2027
Historical Period2017-2021
UnitValue (USD Million)
Key Companies ProfiledCONMED Corporation (United States), Medtronic Plc (Ireland), Olympus (Japan), Becton, Dickinson and Company (United States), Boston Scientific Corporation (United States), Cook Group Incorporated (United States), Argon Medical Devices, Inc (United States), INRAD Inc. (United States), Somatex Medical Technologies (Germany) and Stryker Corporation (United States)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region or narrow down segments in the final scope subject to feasibility


AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics of major and emerging geographies across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.

Key Players of Biopsy Needle Market Study:
CONMED Corporation (United States), Medtronic Plc (Ireland), Olympus (Japan), Becton, Dickinson and Company (United States), Boston Scientific Corporation (United States), Cook Group Incorporated (United States), Argon Medical Devices, Inc (United States), INRAD Inc. (United States), Somatex Medical Technologies (Germany) and Stryker Corporation (United States)

Biopsy Needle Market Segment Analysis
ScopeSub-Segments
Application / End UserTumor, Infection, Inflammation and Others
WorkingFully Automatic,Semi-Automatic
UtilityDisposable Needle,Non Disposable Needle
End UserHospitals,Clinics,Ambulatory Surgical Centers


Influencing Trend:
Emergence of Liquid Biopsy

Market Growth Drivers:
Rising Prevalence of Cancer, Cancer Awareness Initiatives Undertaken By Governments and Global Health Organizations and Increasing Preference for Minimally Invasive Biopsies

Challenges:
Underdeveloped Healthcare Infrastructure and Dearth of Well-Trained Radiologists and Oncologists

Restraints:
Risk of Infections Associated With the use of Biopsy Needles

Opportunities:
Emerging Economies

Some of the other players that are also part of study are Cardinal Health (United States), Remington Medical (United States), HAKKO CO.,LTD (Japan) and Merit Medical Systems (United States). The Global Biopsy Needle market is gaining huge competition due to involvement of United States companies that constantly invest in research & development to meet market expectation with new innovation.




Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Biopsy Needle market.
In order to reach an exhaustive list of functional and relevant players, various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep into important geographies by players, and a thorough validation test is conducted to reach the most relevant players for survey in Biopsy Needle market.
Identification of total players or companies operating in the global market which is further concentrated to fewer or most impacting players which are considered under the report’s scope. In order to make a priority list sorting is done based on revenue generated based on the latest reporting with the help of paid databases such as Factiva, Bloomberg, etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Global Biopsy Needle Manufacturers and Suppliers, Research and Development Companies, Market Research and Consulting Service Providers and Academic Institutes and Universities.

This helps us to gather the data for the players’ revenue, operating cycle and expense, profit along with product or service growth, etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that include Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, Annual reports, press releases etc.

Report Objectives / Segmentation Covered

By Application
  • Tumor
  • Infection
  • Inflammation
  • Others
By Working
  • Fully Automatic
  • Semi-Automatic

By Utility
  • Disposable Needle
  • Non Disposable Needle

By End User
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Prevalence of Cancer
      • 3.2.2. Cancer Awareness Initiatives Undertaken By Governments and Global Health Organizations
      • 3.2.3. Increasing Preference for Minimally Invasive Biopsies
    • 3.3. Market Challenges
      • 3.3.1. Underdeveloped Healthcare Infrastructure and Dearth of Well-Trained Radiologists and Oncologists
    • 3.4. Market Trends
      • 3.4.1. Emergence of Liquid Biopsy
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Biopsy Needle, by Application, Working, Utility, End User and Region (value, volume and price ) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Biopsy Needle (Value)
      • 5.2.1. Global Biopsy Needle by: Application (Value)
        • 5.2.1.1. Tumor
        • 5.2.1.2. Infection
        • 5.2.1.3. Inflammation
        • 5.2.1.4. Others
      • 5.2.2. Global Biopsy Needle by: Working (Value)
        • 5.2.2.1. Fully Automatic
        • 5.2.2.2. Semi-Automatic
      • 5.2.3. Global Biopsy Needle by: Utility (Value)
        • 5.2.3.1. Disposable Needle
        • 5.2.3.2. Non Disposable Needle
      • 5.2.4. Global Biopsy Needle by: End User (Value)
        • 5.2.4.1. Hospitals
        • 5.2.4.2. Clinics
        • 5.2.4.3. Ambulatory Surgical Centers
      • 5.2.5. Global Biopsy Needle Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Biopsy Needle (Volume)
      • 5.3.1. Global Biopsy Needle by: Application (Volume)
        • 5.3.1.1. Tumor
        • 5.3.1.2. Infection
        • 5.3.1.3. Inflammation
        • 5.3.1.4. Others
      • 5.3.2. Global Biopsy Needle by: Working (Volume)
        • 5.3.2.1. Fully Automatic
        • 5.3.2.2. Semi-Automatic
      • 5.3.3. Global Biopsy Needle by: Utility (Volume)
        • 5.3.3.1. Disposable Needle
        • 5.3.3.2. Non Disposable Needle
      • 5.3.4. Global Biopsy Needle by: End User (Volume)
        • 5.3.4.1. Hospitals
        • 5.3.4.2. Clinics
        • 5.3.4.3. Ambulatory Surgical Centers
      • 5.3.5. Global Biopsy Needle Region
        • 5.3.5.1. South America
          • 5.3.5.1.1. Brazil
          • 5.3.5.1.2. Argentina
          • 5.3.5.1.3. Rest of South America
        • 5.3.5.2. Asia Pacific
          • 5.3.5.2.1. China
          • 5.3.5.2.2. Japan
          • 5.3.5.2.3. India
          • 5.3.5.2.4. South Korea
          • 5.3.5.2.5. Taiwan
          • 5.3.5.2.6. Australia
          • 5.3.5.2.7. Rest of Asia-Pacific
        • 5.3.5.3. Europe
          • 5.3.5.3.1. Germany
          • 5.3.5.3.2. France
          • 5.3.5.3.3. Italy
          • 5.3.5.3.4. United Kingdom
          • 5.3.5.3.5. Netherlands
          • 5.3.5.3.6. Rest of Europe
        • 5.3.5.4. MEA
          • 5.3.5.4.1. Middle East
          • 5.3.5.4.2. Africa
        • 5.3.5.5. North America
          • 5.3.5.5.1. United States
          • 5.3.5.5.2. Canada
          • 5.3.5.5.3. Mexico
    • 5.4. Global Biopsy Needle (Price)
  • 6. Biopsy Needle: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. CONMED Corporation (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Medtronic Plc (Ireland)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Olympus (Japan)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Becton, Dickinson and Company (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Boston Scientific Corporation (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Cook Group Incorporated (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Argon Medical Devices, Inc (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. INRAD Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Somatex Medical Technologies (Germany)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Stryker Corporation (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Biopsy Needle Sale, by Application, Working, Utility, End User and Region (value, volume and price ) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Biopsy Needle (Value)
      • 7.2.1. Global Biopsy Needle by: Application (Value)
        • 7.2.1.1. Tumor
        • 7.2.1.2. Infection
        • 7.2.1.3. Inflammation
        • 7.2.1.4. Others
      • 7.2.2. Global Biopsy Needle by: Working (Value)
        • 7.2.2.1. Fully Automatic
        • 7.2.2.2. Semi-Automatic
      • 7.2.3. Global Biopsy Needle by: Utility (Value)
        • 7.2.3.1. Disposable Needle
        • 7.2.3.2. Non Disposable Needle
      • 7.2.4. Global Biopsy Needle by: End User (Value)
        • 7.2.4.1. Hospitals
        • 7.2.4.2. Clinics
        • 7.2.4.3. Ambulatory Surgical Centers
      • 7.2.5. Global Biopsy Needle Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Biopsy Needle (Volume)
      • 7.3.1. Global Biopsy Needle by: Application (Volume)
        • 7.3.1.1. Tumor
        • 7.3.1.2. Infection
        • 7.3.1.3. Inflammation
        • 7.3.1.4. Others
      • 7.3.2. Global Biopsy Needle by: Working (Volume)
        • 7.3.2.1. Fully Automatic
        • 7.3.2.2. Semi-Automatic
      • 7.3.3. Global Biopsy Needle by: Utility (Volume)
        • 7.3.3.1. Disposable Needle
        • 7.3.3.2. Non Disposable Needle
      • 7.3.4. Global Biopsy Needle by: End User (Volume)
        • 7.3.4.1. Hospitals
        • 7.3.4.2. Clinics
        • 7.3.4.3. Ambulatory Surgical Centers
      • 7.3.5. Global Biopsy Needle Region
        • 7.3.5.1. South America
          • 7.3.5.1.1. Brazil
          • 7.3.5.1.2. Argentina
          • 7.3.5.1.3. Rest of South America
        • 7.3.5.2. Asia Pacific
          • 7.3.5.2.1. China
          • 7.3.5.2.2. Japan
          • 7.3.5.2.3. India
          • 7.3.5.2.4. South Korea
          • 7.3.5.2.5. Taiwan
          • 7.3.5.2.6. Australia
          • 7.3.5.2.7. Rest of Asia-Pacific
        • 7.3.5.3. Europe
          • 7.3.5.3.1. Germany
          • 7.3.5.3.2. France
          • 7.3.5.3.3. Italy
          • 7.3.5.3.4. United Kingdom
          • 7.3.5.3.5. Netherlands
          • 7.3.5.3.6. Rest of Europe
        • 7.3.5.4. MEA
          • 7.3.5.4.1. Middle East
          • 7.3.5.4.2. Africa
        • 7.3.5.5. North America
          • 7.3.5.5.1. United States
          • 7.3.5.5.2. Canada
          • 7.3.5.5.3. Mexico
    • 7.4. Global Biopsy Needle (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Biopsy Needle: by Application(USD Million)
  • Table 2. Biopsy Needle Tumor , by Region USD Million (2016-2021)
  • Table 3. Biopsy Needle Infection , by Region USD Million (2016-2021)
  • Table 4. Biopsy Needle Inflammation , by Region USD Million (2016-2021)
  • Table 5. Biopsy Needle Others , by Region USD Million (2016-2021)
  • Table 6. Biopsy Needle: by Working(USD Million)
  • Table 7. Biopsy Needle Fully Automatic , by Region USD Million (2016-2021)
  • Table 8. Biopsy Needle Semi-Automatic , by Region USD Million (2016-2021)
  • Table 9. Biopsy Needle: by Utility(USD Million)
  • Table 10. Biopsy Needle Disposable Needle , by Region USD Million (2016-2021)
  • Table 11. Biopsy Needle Non Disposable Needle , by Region USD Million (2016-2021)
  • Table 12. Biopsy Needle: by End User(USD Million)
  • Table 13. Biopsy Needle Hospitals , by Region USD Million (2016-2021)
  • Table 14. Biopsy Needle Clinics , by Region USD Million (2016-2021)
  • Table 15. Biopsy Needle Ambulatory Surgical Centers , by Region USD Million (2016-2021)
  • Table 16. South America Biopsy Needle, by Country USD Million (2016-2021)
  • Table 17. South America Biopsy Needle, by Application USD Million (2016-2021)
  • Table 18. South America Biopsy Needle, by Working USD Million (2016-2021)
  • Table 19. South America Biopsy Needle, by Utility USD Million (2016-2021)
  • Table 20. South America Biopsy Needle, by End User USD Million (2016-2021)
  • Table 21. Brazil Biopsy Needle, by Application USD Million (2016-2021)
  • Table 22. Brazil Biopsy Needle, by Working USD Million (2016-2021)
  • Table 23. Brazil Biopsy Needle, by Utility USD Million (2016-2021)
  • Table 24. Brazil Biopsy Needle, by End User USD Million (2016-2021)
  • Table 25. Argentina Biopsy Needle, by Application USD Million (2016-2021)
  • Table 26. Argentina Biopsy Needle, by Working USD Million (2016-2021)
  • Table 27. Argentina Biopsy Needle, by Utility USD Million (2016-2021)
  • Table 28. Argentina Biopsy Needle, by End User USD Million (2016-2021)
  • Table 29. Rest of South America Biopsy Needle, by Application USD Million (2016-2021)
  • Table 30. Rest of South America Biopsy Needle, by Working USD Million (2016-2021)
  • Table 31. Rest of South America Biopsy Needle, by Utility USD Million (2016-2021)
  • Table 32. Rest of South America Biopsy Needle, by End User USD Million (2016-2021)
  • Table 33. Asia Pacific Biopsy Needle, by Country USD Million (2016-2021)
  • Table 34. Asia Pacific Biopsy Needle, by Application USD Million (2016-2021)
  • Table 35. Asia Pacific Biopsy Needle, by Working USD Million (2016-2021)
  • Table 36. Asia Pacific Biopsy Needle, by Utility USD Million (2016-2021)
  • Table 37. Asia Pacific Biopsy Needle, by End User USD Million (2016-2021)
  • Table 38. China Biopsy Needle, by Application USD Million (2016-2021)
  • Table 39. China Biopsy Needle, by Working USD Million (2016-2021)
  • Table 40. China Biopsy Needle, by Utility USD Million (2016-2021)
  • Table 41. China Biopsy Needle, by End User USD Million (2016-2021)
  • Table 42. Japan Biopsy Needle, by Application USD Million (2016-2021)
  • Table 43. Japan Biopsy Needle, by Working USD Million (2016-2021)
  • Table 44. Japan Biopsy Needle, by Utility USD Million (2016-2021)
  • Table 45. Japan Biopsy Needle, by End User USD Million (2016-2021)
  • Table 46. India Biopsy Needle, by Application USD Million (2016-2021)
  • Table 47. India Biopsy Needle, by Working USD Million (2016-2021)
  • Table 48. India Biopsy Needle, by Utility USD Million (2016-2021)
  • Table 49. India Biopsy Needle, by End User USD Million (2016-2021)
  • Table 50. South Korea Biopsy Needle, by Application USD Million (2016-2021)
  • Table 51. South Korea Biopsy Needle, by Working USD Million (2016-2021)
  • Table 52. South Korea Biopsy Needle, by Utility USD Million (2016-2021)
  • Table 53. South Korea Biopsy Needle, by End User USD Million (2016-2021)
  • Table 54. Taiwan Biopsy Needle, by Application USD Million (2016-2021)
  • Table 55. Taiwan Biopsy Needle, by Working USD Million (2016-2021)
  • Table 56. Taiwan Biopsy Needle, by Utility USD Million (2016-2021)
  • Table 57. Taiwan Biopsy Needle, by End User USD Million (2016-2021)
  • Table 58. Australia Biopsy Needle, by Application USD Million (2016-2021)
  • Table 59. Australia Biopsy Needle, by Working USD Million (2016-2021)
  • Table 60. Australia Biopsy Needle, by Utility USD Million (2016-2021)
  • Table 61. Australia Biopsy Needle, by End User USD Million (2016-2021)
  • Table 62. Rest of Asia-Pacific Biopsy Needle, by Application USD Million (2016-2021)
  • Table 63. Rest of Asia-Pacific Biopsy Needle, by Working USD Million (2016-2021)
  • Table 64. Rest of Asia-Pacific Biopsy Needle, by Utility USD Million (2016-2021)
  • Table 65. Rest of Asia-Pacific Biopsy Needle, by End User USD Million (2016-2021)
  • Table 66. Europe Biopsy Needle, by Country USD Million (2016-2021)
  • Table 67. Europe Biopsy Needle, by Application USD Million (2016-2021)
  • Table 68. Europe Biopsy Needle, by Working USD Million (2016-2021)
  • Table 69. Europe Biopsy Needle, by Utility USD Million (2016-2021)
  • Table 70. Europe Biopsy Needle, by End User USD Million (2016-2021)
  • Table 71. Germany Biopsy Needle, by Application USD Million (2016-2021)
  • Table 72. Germany Biopsy Needle, by Working USD Million (2016-2021)
  • Table 73. Germany Biopsy Needle, by Utility USD Million (2016-2021)
  • Table 74. Germany Biopsy Needle, by End User USD Million (2016-2021)
  • Table 75. France Biopsy Needle, by Application USD Million (2016-2021)
  • Table 76. France Biopsy Needle, by Working USD Million (2016-2021)
  • Table 77. France Biopsy Needle, by Utility USD Million (2016-2021)
  • Table 78. France Biopsy Needle, by End User USD Million (2016-2021)
  • Table 79. Italy Biopsy Needle, by Application USD Million (2016-2021)
  • Table 80. Italy Biopsy Needle, by Working USD Million (2016-2021)
  • Table 81. Italy Biopsy Needle, by Utility USD Million (2016-2021)
  • Table 82. Italy Biopsy Needle, by End User USD Million (2016-2021)
  • Table 83. United Kingdom Biopsy Needle, by Application USD Million (2016-2021)
  • Table 84. United Kingdom Biopsy Needle, by Working USD Million (2016-2021)
  • Table 85. United Kingdom Biopsy Needle, by Utility USD Million (2016-2021)
  • Table 86. United Kingdom Biopsy Needle, by End User USD Million (2016-2021)
  • Table 87. Netherlands Biopsy Needle, by Application USD Million (2016-2021)
  • Table 88. Netherlands Biopsy Needle, by Working USD Million (2016-2021)
  • Table 89. Netherlands Biopsy Needle, by Utility USD Million (2016-2021)
  • Table 90. Netherlands Biopsy Needle, by End User USD Million (2016-2021)
  • Table 91. Rest of Europe Biopsy Needle, by Application USD Million (2016-2021)
  • Table 92. Rest of Europe Biopsy Needle, by Working USD Million (2016-2021)
  • Table 93. Rest of Europe Biopsy Needle, by Utility USD Million (2016-2021)
  • Table 94. Rest of Europe Biopsy Needle, by End User USD Million (2016-2021)
  • Table 95. MEA Biopsy Needle, by Country USD Million (2016-2021)
  • Table 96. MEA Biopsy Needle, by Application USD Million (2016-2021)
  • Table 97. MEA Biopsy Needle, by Working USD Million (2016-2021)
  • Table 98. MEA Biopsy Needle, by Utility USD Million (2016-2021)
  • Table 99. MEA Biopsy Needle, by End User USD Million (2016-2021)
  • Table 100. Middle East Biopsy Needle, by Application USD Million (2016-2021)
  • Table 101. Middle East Biopsy Needle, by Working USD Million (2016-2021)
  • Table 102. Middle East Biopsy Needle, by Utility USD Million (2016-2021)
  • Table 103. Middle East Biopsy Needle, by End User USD Million (2016-2021)
  • Table 104. Africa Biopsy Needle, by Application USD Million (2016-2021)
  • Table 105. Africa Biopsy Needle, by Working USD Million (2016-2021)
  • Table 106. Africa Biopsy Needle, by Utility USD Million (2016-2021)
  • Table 107. Africa Biopsy Needle, by End User USD Million (2016-2021)
  • Table 108. North America Biopsy Needle, by Country USD Million (2016-2021)
  • Table 109. North America Biopsy Needle, by Application USD Million (2016-2021)
  • Table 110. North America Biopsy Needle, by Working USD Million (2016-2021)
  • Table 111. North America Biopsy Needle, by Utility USD Million (2016-2021)
  • Table 112. North America Biopsy Needle, by End User USD Million (2016-2021)
  • Table 113. United States Biopsy Needle, by Application USD Million (2016-2021)
  • Table 114. United States Biopsy Needle, by Working USD Million (2016-2021)
  • Table 115. United States Biopsy Needle, by Utility USD Million (2016-2021)
  • Table 116. United States Biopsy Needle, by End User USD Million (2016-2021)
  • Table 117. Canada Biopsy Needle, by Application USD Million (2016-2021)
  • Table 118. Canada Biopsy Needle, by Working USD Million (2016-2021)
  • Table 119. Canada Biopsy Needle, by Utility USD Million (2016-2021)
  • Table 120. Canada Biopsy Needle, by End User USD Million (2016-2021)
  • Table 121. Mexico Biopsy Needle, by Application USD Million (2016-2021)
  • Table 122. Mexico Biopsy Needle, by Working USD Million (2016-2021)
  • Table 123. Mexico Biopsy Needle, by Utility USD Million (2016-2021)
  • Table 124. Mexico Biopsy Needle, by End User USD Million (2016-2021)
  • Table 125. Biopsy Needle Sales: by Application(K Unit)
  • Table 126. Biopsy Needle Sales Tumor , by Region K Unit (2016-2021)
  • Table 127. Biopsy Needle Sales Infection , by Region K Unit (2016-2021)
  • Table 128. Biopsy Needle Sales Inflammation , by Region K Unit (2016-2021)
  • Table 129. Biopsy Needle Sales Others , by Region K Unit (2016-2021)
  • Table 130. Biopsy Needle Sales: by Working(K Unit)
  • Table 131. Biopsy Needle Sales Fully Automatic , by Region K Unit (2016-2021)
  • Table 132. Biopsy Needle Sales Semi-Automatic , by Region K Unit (2016-2021)
  • Table 133. Biopsy Needle Sales: by Utility(K Unit)
  • Table 134. Biopsy Needle Sales Disposable Needle , by Region K Unit (2016-2021)
  • Table 135. Biopsy Needle Sales Non Disposable Needle , by Region K Unit (2016-2021)
  • Table 136. Biopsy Needle Sales: by End User(K Unit)
  • Table 137. Biopsy Needle Sales Hospitals , by Region K Unit (2016-2021)
  • Table 138. Biopsy Needle Sales Clinics , by Region K Unit (2016-2021)
  • Table 139. Biopsy Needle Sales Ambulatory Surgical Centers , by Region K Unit (2016-2021)
  • Table 140. South America Biopsy Needle Sales, by Country K Unit (2016-2021)
  • Table 141. South America Biopsy Needle Sales, by Application K Unit (2016-2021)
  • Table 142. South America Biopsy Needle Sales, by Working K Unit (2016-2021)
  • Table 143. South America Biopsy Needle Sales, by Utility K Unit (2016-2021)
  • Table 144. South America Biopsy Needle Sales, by End User K Unit (2016-2021)
  • Table 145. Brazil Biopsy Needle Sales, by Application K Unit (2016-2021)
  • Table 146. Brazil Biopsy Needle Sales, by Working K Unit (2016-2021)
  • Table 147. Brazil Biopsy Needle Sales, by Utility K Unit (2016-2021)
  • Table 148. Brazil Biopsy Needle Sales, by End User K Unit (2016-2021)
  • Table 149. Argentina Biopsy Needle Sales, by Application K Unit (2016-2021)
  • Table 150. Argentina Biopsy Needle Sales, by Working K Unit (2016-2021)
  • Table 151. Argentina Biopsy Needle Sales, by Utility K Unit (2016-2021)
  • Table 152. Argentina Biopsy Needle Sales, by End User K Unit (2016-2021)
  • Table 153. Rest of South America Biopsy Needle Sales, by Application K Unit (2016-2021)
  • Table 154. Rest of South America Biopsy Needle Sales, by Working K Unit (2016-2021)
  • Table 155. Rest of South America Biopsy Needle Sales, by Utility K Unit (2016-2021)
  • Table 156. Rest of South America Biopsy Needle Sales, by End User K Unit (2016-2021)
  • Table 157. Asia Pacific Biopsy Needle Sales, by Country K Unit (2016-2021)
  • Table 158. Asia Pacific Biopsy Needle Sales, by Application K Unit (2016-2021)
  • Table 159. Asia Pacific Biopsy Needle Sales, by Working K Unit (2016-2021)
  • Table 160. Asia Pacific Biopsy Needle Sales, by Utility K Unit (2016-2021)
  • Table 161. Asia Pacific Biopsy Needle Sales, by End User K Unit (2016-2021)
  • Table 162. China Biopsy Needle Sales, by Application K Unit (2016-2021)
  • Table 163. China Biopsy Needle Sales, by Working K Unit (2016-2021)
  • Table 164. China Biopsy Needle Sales, by Utility K Unit (2016-2021)
  • Table 165. China Biopsy Needle Sales, by End User K Unit (2016-2021)
  • Table 166. Japan Biopsy Needle Sales, by Application K Unit (2016-2021)
  • Table 167. Japan Biopsy Needle Sales, by Working K Unit (2016-2021)
  • Table 168. Japan Biopsy Needle Sales, by Utility K Unit (2016-2021)
  • Table 169. Japan Biopsy Needle Sales, by End User K Unit (2016-2021)
  • Table 170. India Biopsy Needle Sales, by Application K Unit (2016-2021)
  • Table 171. India Biopsy Needle Sales, by Working K Unit (2016-2021)
  • Table 172. India Biopsy Needle Sales, by Utility K Unit (2016-2021)
  • Table 173. India Biopsy Needle Sales, by End User K Unit (2016-2021)
  • Table 174. South Korea Biopsy Needle Sales, by Application K Unit (2016-2021)
  • Table 175. South Korea Biopsy Needle Sales, by Working K Unit (2016-2021)
  • Table 176. South Korea Biopsy Needle Sales, by Utility K Unit (2016-2021)
  • Table 177. South Korea Biopsy Needle Sales, by End User K Unit (2016-2021)
  • Table 178. Taiwan Biopsy Needle Sales, by Application K Unit (2016-2021)
  • Table 179. Taiwan Biopsy Needle Sales, by Working K Unit (2016-2021)
  • Table 180. Taiwan Biopsy Needle Sales, by Utility K Unit (2016-2021)
  • Table 181. Taiwan Biopsy Needle Sales, by End User K Unit (2016-2021)
  • Table 182. Australia Biopsy Needle Sales, by Application K Unit (2016-2021)
  • Table 183. Australia Biopsy Needle Sales, by Working K Unit (2016-2021)
  • Table 184. Australia Biopsy Needle Sales, by Utility K Unit (2016-2021)
  • Table 185. Australia Biopsy Needle Sales, by End User K Unit (2016-2021)
  • Table 186. Rest of Asia-Pacific Biopsy Needle Sales, by Application K Unit (2016-2021)
  • Table 187. Rest of Asia-Pacific Biopsy Needle Sales, by Working K Unit (2016-2021)
  • Table 188. Rest of Asia-Pacific Biopsy Needle Sales, by Utility K Unit (2016-2021)
  • Table 189. Rest of Asia-Pacific Biopsy Needle Sales, by End User K Unit (2016-2021)
  • Table 190. Europe Biopsy Needle Sales, by Country K Unit (2016-2021)
  • Table 191. Europe Biopsy Needle Sales, by Application K Unit (2016-2021)
  • Table 192. Europe Biopsy Needle Sales, by Working K Unit (2016-2021)
  • Table 193. Europe Biopsy Needle Sales, by Utility K Unit (2016-2021)
  • Table 194. Europe Biopsy Needle Sales, by End User K Unit (2016-2021)
  • Table 195. Germany Biopsy Needle Sales, by Application K Unit (2016-2021)
  • Table 196. Germany Biopsy Needle Sales, by Working K Unit (2016-2021)
  • Table 197. Germany Biopsy Needle Sales, by Utility K Unit (2016-2021)
  • Table 198. Germany Biopsy Needle Sales, by End User K Unit (2016-2021)
  • Table 199. France Biopsy Needle Sales, by Application K Unit (2016-2021)
  • Table 200. France Biopsy Needle Sales, by Working K Unit (2016-2021)
  • Table 201. France Biopsy Needle Sales, by Utility K Unit (2016-2021)
  • Table 202. France Biopsy Needle Sales, by End User K Unit (2016-2021)
  • Table 203. Italy Biopsy Needle Sales, by Application K Unit (2016-2021)
  • Table 204. Italy Biopsy Needle Sales, by Working K Unit (2016-2021)
  • Table 205. Italy Biopsy Needle Sales, by Utility K Unit (2016-2021)
  • Table 206. Italy Biopsy Needle Sales, by End User K Unit (2016-2021)
  • Table 207. United Kingdom Biopsy Needle Sales, by Application K Unit (2016-2021)
  • Table 208. United Kingdom Biopsy Needle Sales, by Working K Unit (2016-2021)
  • Table 209. United Kingdom Biopsy Needle Sales, by Utility K Unit (2016-2021)
  • Table 210. United Kingdom Biopsy Needle Sales, by End User K Unit (2016-2021)
  • Table 211. Netherlands Biopsy Needle Sales, by Application K Unit (2016-2021)
  • Table 212. Netherlands Biopsy Needle Sales, by Working K Unit (2016-2021)
  • Table 213. Netherlands Biopsy Needle Sales, by Utility K Unit (2016-2021)
  • Table 214. Netherlands Biopsy Needle Sales, by End User K Unit (2016-2021)
  • Table 215. Rest of Europe Biopsy Needle Sales, by Application K Unit (2016-2021)
  • Table 216. Rest of Europe Biopsy Needle Sales, by Working K Unit (2016-2021)
  • Table 217. Rest of Europe Biopsy Needle Sales, by Utility K Unit (2016-2021)
  • Table 218. Rest of Europe Biopsy Needle Sales, by End User K Unit (2016-2021)
  • Table 219. MEA Biopsy Needle Sales, by Country K Unit (2016-2021)
  • Table 220. MEA Biopsy Needle Sales, by Application K Unit (2016-2021)
  • Table 221. MEA Biopsy Needle Sales, by Working K Unit (2016-2021)
  • Table 222. MEA Biopsy Needle Sales, by Utility K Unit (2016-2021)
  • Table 223. MEA Biopsy Needle Sales, by End User K Unit (2016-2021)
  • Table 224. Middle East Biopsy Needle Sales, by Application K Unit (2016-2021)
  • Table 225. Middle East Biopsy Needle Sales, by Working K Unit (2016-2021)
  • Table 226. Middle East Biopsy Needle Sales, by Utility K Unit (2016-2021)
  • Table 227. Middle East Biopsy Needle Sales, by End User K Unit (2016-2021)
  • Table 228. Africa Biopsy Needle Sales, by Application K Unit (2016-2021)
  • Table 229. Africa Biopsy Needle Sales, by Working K Unit (2016-2021)
  • Table 230. Africa Biopsy Needle Sales, by Utility K Unit (2016-2021)
  • Table 231. Africa Biopsy Needle Sales, by End User K Unit (2016-2021)
  • Table 232. North America Biopsy Needle Sales, by Country K Unit (2016-2021)
  • Table 233. North America Biopsy Needle Sales, by Application K Unit (2016-2021)
  • Table 234. North America Biopsy Needle Sales, by Working K Unit (2016-2021)
  • Table 235. North America Biopsy Needle Sales, by Utility K Unit (2016-2021)
  • Table 236. North America Biopsy Needle Sales, by End User K Unit (2016-2021)
  • Table 237. United States Biopsy Needle Sales, by Application K Unit (2016-2021)
  • Table 238. United States Biopsy Needle Sales, by Working K Unit (2016-2021)
  • Table 239. United States Biopsy Needle Sales, by Utility K Unit (2016-2021)
  • Table 240. United States Biopsy Needle Sales, by End User K Unit (2016-2021)
  • Table 241. Canada Biopsy Needle Sales, by Application K Unit (2016-2021)
  • Table 242. Canada Biopsy Needle Sales, by Working K Unit (2016-2021)
  • Table 243. Canada Biopsy Needle Sales, by Utility K Unit (2016-2021)
  • Table 244. Canada Biopsy Needle Sales, by End User K Unit (2016-2021)
  • Table 245. Mexico Biopsy Needle Sales, by Application K Unit (2016-2021)
  • Table 246. Mexico Biopsy Needle Sales, by Working K Unit (2016-2021)
  • Table 247. Mexico Biopsy Needle Sales, by Utility K Unit (2016-2021)
  • Table 248. Mexico Biopsy Needle Sales, by End User K Unit (2016-2021)
  • Table 249. Company Basic Information, Sales Area and Its Competitors
  • Table 250. Company Basic Information, Sales Area and Its Competitors
  • Table 251. Company Basic Information, Sales Area and Its Competitors
  • Table 252. Company Basic Information, Sales Area and Its Competitors
  • Table 253. Company Basic Information, Sales Area and Its Competitors
  • Table 254. Company Basic Information, Sales Area and Its Competitors
  • Table 255. Company Basic Information, Sales Area and Its Competitors
  • Table 256. Company Basic Information, Sales Area and Its Competitors
  • Table 257. Company Basic Information, Sales Area and Its Competitors
  • Table 258. Company Basic Information, Sales Area and Its Competitors
  • Table 259. Biopsy Needle: by Application(USD Million)
  • Table 260. Biopsy Needle Tumor , by Region USD Million (2022-2027)
  • Table 261. Biopsy Needle Infection , by Region USD Million (2022-2027)
  • Table 262. Biopsy Needle Inflammation , by Region USD Million (2022-2027)
  • Table 263. Biopsy Needle Others , by Region USD Million (2022-2027)
  • Table 264. Biopsy Needle: by Working(USD Million)
  • Table 265. Biopsy Needle Fully Automatic , by Region USD Million (2022-2027)
  • Table 266. Biopsy Needle Semi-Automatic , by Region USD Million (2022-2027)
  • Table 267. Biopsy Needle: by Utility(USD Million)
  • Table 268. Biopsy Needle Disposable Needle , by Region USD Million (2022-2027)
  • Table 269. Biopsy Needle Non Disposable Needle , by Region USD Million (2022-2027)
  • Table 270. Biopsy Needle: by End User(USD Million)
  • Table 271. Biopsy Needle Hospitals , by Region USD Million (2022-2027)
  • Table 272. Biopsy Needle Clinics , by Region USD Million (2022-2027)
  • Table 273. Biopsy Needle Ambulatory Surgical Centers , by Region USD Million (2022-2027)
  • Table 274. South America Biopsy Needle, by Country USD Million (2022-2027)
  • Table 275. South America Biopsy Needle, by Application USD Million (2022-2027)
  • Table 276. South America Biopsy Needle, by Working USD Million (2022-2027)
  • Table 277. South America Biopsy Needle, by Utility USD Million (2022-2027)
  • Table 278. South America Biopsy Needle, by End User USD Million (2022-2027)
  • Table 279. Brazil Biopsy Needle, by Application USD Million (2022-2027)
  • Table 280. Brazil Biopsy Needle, by Working USD Million (2022-2027)
  • Table 281. Brazil Biopsy Needle, by Utility USD Million (2022-2027)
  • Table 282. Brazil Biopsy Needle, by End User USD Million (2022-2027)
  • Table 283. Argentina Biopsy Needle, by Application USD Million (2022-2027)
  • Table 284. Argentina Biopsy Needle, by Working USD Million (2022-2027)
  • Table 285. Argentina Biopsy Needle, by Utility USD Million (2022-2027)
  • Table 286. Argentina Biopsy Needle, by End User USD Million (2022-2027)
  • Table 287. Rest of South America Biopsy Needle, by Application USD Million (2022-2027)
  • Table 288. Rest of South America Biopsy Needle, by Working USD Million (2022-2027)
  • Table 289. Rest of South America Biopsy Needle, by Utility USD Million (2022-2027)
  • Table 290. Rest of South America Biopsy Needle, by End User USD Million (2022-2027)
  • Table 291. Asia Pacific Biopsy Needle, by Country USD Million (2022-2027)
  • Table 292. Asia Pacific Biopsy Needle, by Application USD Million (2022-2027)
  • Table 293. Asia Pacific Biopsy Needle, by Working USD Million (2022-2027)
  • Table 294. Asia Pacific Biopsy Needle, by Utility USD Million (2022-2027)
  • Table 295. Asia Pacific Biopsy Needle, by End User USD Million (2022-2027)
  • Table 296. China Biopsy Needle, by Application USD Million (2022-2027)
  • Table 297. China Biopsy Needle, by Working USD Million (2022-2027)
  • Table 298. China Biopsy Needle, by Utility USD Million (2022-2027)
  • Table 299. China Biopsy Needle, by End User USD Million (2022-2027)
  • Table 300. Japan Biopsy Needle, by Application USD Million (2022-2027)
  • Table 301. Japan Biopsy Needle, by Working USD Million (2022-2027)
  • Table 302. Japan Biopsy Needle, by Utility USD Million (2022-2027)
  • Table 303. Japan Biopsy Needle, by End User USD Million (2022-2027)
  • Table 304. India Biopsy Needle, by Application USD Million (2022-2027)
  • Table 305. India Biopsy Needle, by Working USD Million (2022-2027)
  • Table 306. India Biopsy Needle, by Utility USD Million (2022-2027)
  • Table 307. India Biopsy Needle, by End User USD Million (2022-2027)
  • Table 308. South Korea Biopsy Needle, by Application USD Million (2022-2027)
  • Table 309. South Korea Biopsy Needle, by Working USD Million (2022-2027)
  • Table 310. South Korea Biopsy Needle, by Utility USD Million (2022-2027)
  • Table 311. South Korea Biopsy Needle, by End User USD Million (2022-2027)
  • Table 312. Taiwan Biopsy Needle, by Application USD Million (2022-2027)
  • Table 313. Taiwan Biopsy Needle, by Working USD Million (2022-2027)
  • Table 314. Taiwan Biopsy Needle, by Utility USD Million (2022-2027)
  • Table 315. Taiwan Biopsy Needle, by End User USD Million (2022-2027)
  • Table 316. Australia Biopsy Needle, by Application USD Million (2022-2027)
  • Table 317. Australia Biopsy Needle, by Working USD Million (2022-2027)
  • Table 318. Australia Biopsy Needle, by Utility USD Million (2022-2027)
  • Table 319. Australia Biopsy Needle, by End User USD Million (2022-2027)
  • Table 320. Rest of Asia-Pacific Biopsy Needle, by Application USD Million (2022-2027)
  • Table 321. Rest of Asia-Pacific Biopsy Needle, by Working USD Million (2022-2027)
  • Table 322. Rest of Asia-Pacific Biopsy Needle, by Utility USD Million (2022-2027)
  • Table 323. Rest of Asia-Pacific Biopsy Needle, by End User USD Million (2022-2027)
  • Table 324. Europe Biopsy Needle, by Country USD Million (2022-2027)
  • Table 325. Europe Biopsy Needle, by Application USD Million (2022-2027)
  • Table 326. Europe Biopsy Needle, by Working USD Million (2022-2027)
  • Table 327. Europe Biopsy Needle, by Utility USD Million (2022-2027)
  • Table 328. Europe Biopsy Needle, by End User USD Million (2022-2027)
  • Table 329. Germany Biopsy Needle, by Application USD Million (2022-2027)
  • Table 330. Germany Biopsy Needle, by Working USD Million (2022-2027)
  • Table 331. Germany Biopsy Needle, by Utility USD Million (2022-2027)
  • Table 332. Germany Biopsy Needle, by End User USD Million (2022-2027)
  • Table 333. France Biopsy Needle, by Application USD Million (2022-2027)
  • Table 334. France Biopsy Needle, by Working USD Million (2022-2027)
  • Table 335. France Biopsy Needle, by Utility USD Million (2022-2027)
  • Table 336. France Biopsy Needle, by End User USD Million (2022-2027)
  • Table 337. Italy Biopsy Needle, by Application USD Million (2022-2027)
  • Table 338. Italy Biopsy Needle, by Working USD Million (2022-2027)
  • Table 339. Italy Biopsy Needle, by Utility USD Million (2022-2027)
  • Table 340. Italy Biopsy Needle, by End User USD Million (2022-2027)
  • Table 341. United Kingdom Biopsy Needle, by Application USD Million (2022-2027)
  • Table 342. United Kingdom Biopsy Needle, by Working USD Million (2022-2027)
  • Table 343. United Kingdom Biopsy Needle, by Utility USD Million (2022-2027)
  • Table 344. United Kingdom Biopsy Needle, by End User USD Million (2022-2027)
  • Table 345. Netherlands Biopsy Needle, by Application USD Million (2022-2027)
  • Table 346. Netherlands Biopsy Needle, by Working USD Million (2022-2027)
  • Table 347. Netherlands Biopsy Needle, by Utility USD Million (2022-2027)
  • Table 348. Netherlands Biopsy Needle, by End User USD Million (2022-2027)
  • Table 349. Rest of Europe Biopsy Needle, by Application USD Million (2022-2027)
  • Table 350. Rest of Europe Biopsy Needle, by Working USD Million (2022-2027)
  • Table 351. Rest of Europe Biopsy Needle, by Utility USD Million (2022-2027)
  • Table 352. Rest of Europe Biopsy Needle, by End User USD Million (2022-2027)
  • Table 353. MEA Biopsy Needle, by Country USD Million (2022-2027)
  • Table 354. MEA Biopsy Needle, by Application USD Million (2022-2027)
  • Table 355. MEA Biopsy Needle, by Working USD Million (2022-2027)
  • Table 356. MEA Biopsy Needle, by Utility USD Million (2022-2027)
  • Table 357. MEA Biopsy Needle, by End User USD Million (2022-2027)
  • Table 358. Middle East Biopsy Needle, by Application USD Million (2022-2027)
  • Table 359. Middle East Biopsy Needle, by Working USD Million (2022-2027)
  • Table 360. Middle East Biopsy Needle, by Utility USD Million (2022-2027)
  • Table 361. Middle East Biopsy Needle, by End User USD Million (2022-2027)
  • Table 362. Africa Biopsy Needle, by Application USD Million (2022-2027)
  • Table 363. Africa Biopsy Needle, by Working USD Million (2022-2027)
  • Table 364. Africa Biopsy Needle, by Utility USD Million (2022-2027)
  • Table 365. Africa Biopsy Needle, by End User USD Million (2022-2027)
  • Table 366. North America Biopsy Needle, by Country USD Million (2022-2027)
  • Table 367. North America Biopsy Needle, by Application USD Million (2022-2027)
  • Table 368. North America Biopsy Needle, by Working USD Million (2022-2027)
  • Table 369. North America Biopsy Needle, by Utility USD Million (2022-2027)
  • Table 370. North America Biopsy Needle, by End User USD Million (2022-2027)
  • Table 371. United States Biopsy Needle, by Application USD Million (2022-2027)
  • Table 372. United States Biopsy Needle, by Working USD Million (2022-2027)
  • Table 373. United States Biopsy Needle, by Utility USD Million (2022-2027)
  • Table 374. United States Biopsy Needle, by End User USD Million (2022-2027)
  • Table 375. Canada Biopsy Needle, by Application USD Million (2022-2027)
  • Table 376. Canada Biopsy Needle, by Working USD Million (2022-2027)
  • Table 377. Canada Biopsy Needle, by Utility USD Million (2022-2027)
  • Table 378. Canada Biopsy Needle, by End User USD Million (2022-2027)
  • Table 379. Mexico Biopsy Needle, by Application USD Million (2022-2027)
  • Table 380. Mexico Biopsy Needle, by Working USD Million (2022-2027)
  • Table 381. Mexico Biopsy Needle, by Utility USD Million (2022-2027)
  • Table 382. Mexico Biopsy Needle, by End User USD Million (2022-2027)
  • Table 383. Biopsy Needle Sales: by Application(K Unit)
  • Table 384. Biopsy Needle Sales Tumor , by Region K Unit (2022-2027)
  • Table 385. Biopsy Needle Sales Infection , by Region K Unit (2022-2027)
  • Table 386. Biopsy Needle Sales Inflammation , by Region K Unit (2022-2027)
  • Table 387. Biopsy Needle Sales Others , by Region K Unit (2022-2027)
  • Table 388. Biopsy Needle Sales: by Working(K Unit)
  • Table 389. Biopsy Needle Sales Fully Automatic , by Region K Unit (2022-2027)
  • Table 390. Biopsy Needle Sales Semi-Automatic , by Region K Unit (2022-2027)
  • Table 391. Biopsy Needle Sales: by Utility(K Unit)
  • Table 392. Biopsy Needle Sales Disposable Needle , by Region K Unit (2022-2027)
  • Table 393. Biopsy Needle Sales Non Disposable Needle , by Region K Unit (2022-2027)
  • Table 394. Biopsy Needle Sales: by End User(K Unit)
  • Table 395. Biopsy Needle Sales Hospitals , by Region K Unit (2022-2027)
  • Table 396. Biopsy Needle Sales Clinics , by Region K Unit (2022-2027)
  • Table 397. Biopsy Needle Sales Ambulatory Surgical Centers , by Region K Unit (2022-2027)
  • Table 398. South America Biopsy Needle Sales, by Country K Unit (2022-2027)
  • Table 399. South America Biopsy Needle Sales, by Application K Unit (2022-2027)
  • Table 400. South America Biopsy Needle Sales, by Working K Unit (2022-2027)
  • Table 401. South America Biopsy Needle Sales, by Utility K Unit (2022-2027)
  • Table 402. South America Biopsy Needle Sales, by End User K Unit (2022-2027)
  • Table 403. Brazil Biopsy Needle Sales, by Application K Unit (2022-2027)
  • Table 404. Brazil Biopsy Needle Sales, by Working K Unit (2022-2027)
  • Table 405. Brazil Biopsy Needle Sales, by Utility K Unit (2022-2027)
  • Table 406. Brazil Biopsy Needle Sales, by End User K Unit (2022-2027)
  • Table 407. Argentina Biopsy Needle Sales, by Application K Unit (2022-2027)
  • Table 408. Argentina Biopsy Needle Sales, by Working K Unit (2022-2027)
  • Table 409. Argentina Biopsy Needle Sales, by Utility K Unit (2022-2027)
  • Table 410. Argentina Biopsy Needle Sales, by End User K Unit (2022-2027)
  • Table 411. Rest of South America Biopsy Needle Sales, by Application K Unit (2022-2027)
  • Table 412. Rest of South America Biopsy Needle Sales, by Working K Unit (2022-2027)
  • Table 413. Rest of South America Biopsy Needle Sales, by Utility K Unit (2022-2027)
  • Table 414. Rest of South America Biopsy Needle Sales, by End User K Unit (2022-2027)
  • Table 415. Asia Pacific Biopsy Needle Sales, by Country K Unit (2022-2027)
  • Table 416. Asia Pacific Biopsy Needle Sales, by Application K Unit (2022-2027)
  • Table 417. Asia Pacific Biopsy Needle Sales, by Working K Unit (2022-2027)
  • Table 418. Asia Pacific Biopsy Needle Sales, by Utility K Unit (2022-2027)
  • Table 419. Asia Pacific Biopsy Needle Sales, by End User K Unit (2022-2027)
  • Table 420. China Biopsy Needle Sales, by Application K Unit (2022-2027)
  • Table 421. China Biopsy Needle Sales, by Working K Unit (2022-2027)
  • Table 422. China Biopsy Needle Sales, by Utility K Unit (2022-2027)
  • Table 423. China Biopsy Needle Sales, by End User K Unit (2022-2027)
  • Table 424. Japan Biopsy Needle Sales, by Application K Unit (2022-2027)
  • Table 425. Japan Biopsy Needle Sales, by Working K Unit (2022-2027)
  • Table 426. Japan Biopsy Needle Sales, by Utility K Unit (2022-2027)
  • Table 427. Japan Biopsy Needle Sales, by End User K Unit (2022-2027)
  • Table 428. India Biopsy Needle Sales, by Application K Unit (2022-2027)
  • Table 429. India Biopsy Needle Sales, by Working K Unit (2022-2027)
  • Table 430. India Biopsy Needle Sales, by Utility K Unit (2022-2027)
  • Table 431. India Biopsy Needle Sales, by End User K Unit (2022-2027)
  • Table 432. South Korea Biopsy Needle Sales, by Application K Unit (2022-2027)
  • Table 433. South Korea Biopsy Needle Sales, by Working K Unit (2022-2027)
  • Table 434. South Korea Biopsy Needle Sales, by Utility K Unit (2022-2027)
  • Table 435. South Korea Biopsy Needle Sales, by End User K Unit (2022-2027)
  • Table 436. Taiwan Biopsy Needle Sales, by Application K Unit (2022-2027)
  • Table 437. Taiwan Biopsy Needle Sales, by Working K Unit (2022-2027)
  • Table 438. Taiwan Biopsy Needle Sales, by Utility K Unit (2022-2027)
  • Table 439. Taiwan Biopsy Needle Sales, by End User K Unit (2022-2027)
  • Table 440. Australia Biopsy Needle Sales, by Application K Unit (2022-2027)
  • Table 441. Australia Biopsy Needle Sales, by Working K Unit (2022-2027)
  • Table 442. Australia Biopsy Needle Sales, by Utility K Unit (2022-2027)
  • Table 443. Australia Biopsy Needle Sales, by End User K Unit (2022-2027)
  • Table 444. Rest of Asia-Pacific Biopsy Needle Sales, by Application K Unit (2022-2027)
  • Table 445. Rest of Asia-Pacific Biopsy Needle Sales, by Working K Unit (2022-2027)
  • Table 446. Rest of Asia-Pacific Biopsy Needle Sales, by Utility K Unit (2022-2027)
  • Table 447. Rest of Asia-Pacific Biopsy Needle Sales, by End User K Unit (2022-2027)
  • Table 448. Europe Biopsy Needle Sales, by Country K Unit (2022-2027)
  • Table 449. Europe Biopsy Needle Sales, by Application K Unit (2022-2027)
  • Table 450. Europe Biopsy Needle Sales, by Working K Unit (2022-2027)
  • Table 451. Europe Biopsy Needle Sales, by Utility K Unit (2022-2027)
  • Table 452. Europe Biopsy Needle Sales, by End User K Unit (2022-2027)
  • Table 453. Germany Biopsy Needle Sales, by Application K Unit (2022-2027)
  • Table 454. Germany Biopsy Needle Sales, by Working K Unit (2022-2027)
  • Table 455. Germany Biopsy Needle Sales, by Utility K Unit (2022-2027)
  • Table 456. Germany Biopsy Needle Sales, by End User K Unit (2022-2027)
  • Table 457. France Biopsy Needle Sales, by Application K Unit (2022-2027)
  • Table 458. France Biopsy Needle Sales, by Working K Unit (2022-2027)
  • Table 459. France Biopsy Needle Sales, by Utility K Unit (2022-2027)
  • Table 460. France Biopsy Needle Sales, by End User K Unit (2022-2027)
  • Table 461. Italy Biopsy Needle Sales, by Application K Unit (2022-2027)
  • Table 462. Italy Biopsy Needle Sales, by Working K Unit (2022-2027)
  • Table 463. Italy Biopsy Needle Sales, by Utility K Unit (2022-2027)
  • Table 464. Italy Biopsy Needle Sales, by End User K Unit (2022-2027)
  • Table 465. United Kingdom Biopsy Needle Sales, by Application K Unit (2022-2027)
  • Table 466. United Kingdom Biopsy Needle Sales, by Working K Unit (2022-2027)
  • Table 467. United Kingdom Biopsy Needle Sales, by Utility K Unit (2022-2027)
  • Table 468. United Kingdom Biopsy Needle Sales, by End User K Unit (2022-2027)
  • Table 469. Netherlands Biopsy Needle Sales, by Application K Unit (2022-2027)
  • Table 470. Netherlands Biopsy Needle Sales, by Working K Unit (2022-2027)
  • Table 471. Netherlands Biopsy Needle Sales, by Utility K Unit (2022-2027)
  • Table 472. Netherlands Biopsy Needle Sales, by End User K Unit (2022-2027)
  • Table 473. Rest of Europe Biopsy Needle Sales, by Application K Unit (2022-2027)
  • Table 474. Rest of Europe Biopsy Needle Sales, by Working K Unit (2022-2027)
  • Table 475. Rest of Europe Biopsy Needle Sales, by Utility K Unit (2022-2027)
  • Table 476. Rest of Europe Biopsy Needle Sales, by End User K Unit (2022-2027)
  • Table 477. MEA Biopsy Needle Sales, by Country K Unit (2022-2027)
  • Table 478. MEA Biopsy Needle Sales, by Application K Unit (2022-2027)
  • Table 479. MEA Biopsy Needle Sales, by Working K Unit (2022-2027)
  • Table 480. MEA Biopsy Needle Sales, by Utility K Unit (2022-2027)
  • Table 481. MEA Biopsy Needle Sales, by End User K Unit (2022-2027)
  • Table 482. Middle East Biopsy Needle Sales, by Application K Unit (2022-2027)
  • Table 483. Middle East Biopsy Needle Sales, by Working K Unit (2022-2027)
  • Table 484. Middle East Biopsy Needle Sales, by Utility K Unit (2022-2027)
  • Table 485. Middle East Biopsy Needle Sales, by End User K Unit (2022-2027)
  • Table 486. Africa Biopsy Needle Sales, by Application K Unit (2022-2027)
  • Table 487. Africa Biopsy Needle Sales, by Working K Unit (2022-2027)
  • Table 488. Africa Biopsy Needle Sales, by Utility K Unit (2022-2027)
  • Table 489. Africa Biopsy Needle Sales, by End User K Unit (2022-2027)
  • Table 490. North America Biopsy Needle Sales, by Country K Unit (2022-2027)
  • Table 491. North America Biopsy Needle Sales, by Application K Unit (2022-2027)
  • Table 492. North America Biopsy Needle Sales, by Working K Unit (2022-2027)
  • Table 493. North America Biopsy Needle Sales, by Utility K Unit (2022-2027)
  • Table 494. North America Biopsy Needle Sales, by End User K Unit (2022-2027)
  • Table 495. United States Biopsy Needle Sales, by Application K Unit (2022-2027)
  • Table 496. United States Biopsy Needle Sales, by Working K Unit (2022-2027)
  • Table 497. United States Biopsy Needle Sales, by Utility K Unit (2022-2027)
  • Table 498. United States Biopsy Needle Sales, by End User K Unit (2022-2027)
  • Table 499. Canada Biopsy Needle Sales, by Application K Unit (2022-2027)
  • Table 500. Canada Biopsy Needle Sales, by Working K Unit (2022-2027)
  • Table 501. Canada Biopsy Needle Sales, by Utility K Unit (2022-2027)
  • Table 502. Canada Biopsy Needle Sales, by End User K Unit (2022-2027)
  • Table 503. Mexico Biopsy Needle Sales, by Application K Unit (2022-2027)
  • Table 504. Mexico Biopsy Needle Sales, by Working K Unit (2022-2027)
  • Table 505. Mexico Biopsy Needle Sales, by Utility K Unit (2022-2027)
  • Table 506. Mexico Biopsy Needle Sales, by End User K Unit (2022-2027)
  • Table 507. Research Programs/Design for This Report
  • Table 508. Key Data Information from Secondary Sources
  • Table 509. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Biopsy Needle: by Application USD Million (2016-2021)
  • Figure 5. Global Biopsy Needle: by Working USD Million (2016-2021)
  • Figure 6. Global Biopsy Needle: by Utility USD Million (2016-2021)
  • Figure 7. Global Biopsy Needle: by End User USD Million (2016-2021)
  • Figure 8. South America Biopsy Needle Share (%), by Country
  • Figure 9. Asia Pacific Biopsy Needle Share (%), by Country
  • Figure 10. Europe Biopsy Needle Share (%), by Country
  • Figure 11. MEA Biopsy Needle Share (%), by Country
  • Figure 12. North America Biopsy Needle Share (%), by Country
  • Figure 13. Global Biopsy Needle: by Application K Unit (2016-2021)
  • Figure 14. Global Biopsy Needle: by Working K Unit (2016-2021)
  • Figure 15. Global Biopsy Needle: by Utility K Unit (2016-2021)
  • Figure 16. Global Biopsy Needle: by End User K Unit (2016-2021)
  • Figure 17. South America Biopsy Needle Share (%), by Country
  • Figure 18. Asia Pacific Biopsy Needle Share (%), by Country
  • Figure 19. Europe Biopsy Needle Share (%), by Country
  • Figure 20. MEA Biopsy Needle Share (%), by Country
  • Figure 21. North America Biopsy Needle Share (%), by Country
  • Figure 22. Global Biopsy Needle share by Players 2021 (%)
  • Figure 23. Global Biopsy Needle share by Players (Top 3) 2021(%)
  • Figure 24. Global Biopsy Needle share by Players (Top 5) 2021(%)
  • Figure 25. BCG Matrix for key Companies
  • Figure 26. CONMED Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 27. CONMED Corporation (United States) Revenue: by Geography 2021
  • Figure 28. Medtronic Plc (Ireland) Revenue, Net Income and Gross profit
  • Figure 29. Medtronic Plc (Ireland) Revenue: by Geography 2021
  • Figure 30. Olympus (Japan) Revenue, Net Income and Gross profit
  • Figure 31. Olympus (Japan) Revenue: by Geography 2021
  • Figure 32. Becton, Dickinson and Company (United States) Revenue, Net Income and Gross profit
  • Figure 33. Becton, Dickinson and Company (United States) Revenue: by Geography 2021
  • Figure 34. Boston Scientific Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 35. Boston Scientific Corporation (United States) Revenue: by Geography 2021
  • Figure 36. Cook Group Incorporated (United States) Revenue, Net Income and Gross profit
  • Figure 37. Cook Group Incorporated (United States) Revenue: by Geography 2021
  • Figure 38. Argon Medical Devices, Inc (United States) Revenue, Net Income and Gross profit
  • Figure 39. Argon Medical Devices, Inc (United States) Revenue: by Geography 2021
  • Figure 40. INRAD Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 41. INRAD Inc. (United States) Revenue: by Geography 2021
  • Figure 42. Somatex Medical Technologies (Germany) Revenue, Net Income and Gross profit
  • Figure 43. Somatex Medical Technologies (Germany) Revenue: by Geography 2021
  • Figure 44. Stryker Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 45. Stryker Corporation (United States) Revenue: by Geography 2021
  • Figure 46. Global Biopsy Needle: by Application USD Million (2022-2027)
  • Figure 47. Global Biopsy Needle: by Working USD Million (2022-2027)
  • Figure 48. Global Biopsy Needle: by Utility USD Million (2022-2027)
  • Figure 49. Global Biopsy Needle: by End User USD Million (2022-2027)
  • Figure 50. South America Biopsy Needle Share (%), by Country
  • Figure 51. Asia Pacific Biopsy Needle Share (%), by Country
  • Figure 52. Europe Biopsy Needle Share (%), by Country
  • Figure 53. MEA Biopsy Needle Share (%), by Country
  • Figure 54. North America Biopsy Needle Share (%), by Country
  • Figure 55. Global Biopsy Needle: by Application K Unit (2022-2027)
  • Figure 56. Global Biopsy Needle: by Working K Unit (2022-2027)
  • Figure 57. Global Biopsy Needle: by Utility K Unit (2022-2027)
  • Figure 58. Global Biopsy Needle: by End User K Unit (2022-2027)
  • Figure 59. South America Biopsy Needle Share (%), by Country
  • Figure 60. Asia Pacific Biopsy Needle Share (%), by Country
  • Figure 61. Europe Biopsy Needle Share (%), by Country
  • Figure 62. MEA Biopsy Needle Share (%), by Country
  • Figure 63. North America Biopsy Needle Share (%), by Country
List of companies from research coverage that are profiled in the study
  • CONMED Corporation (United States)
  • Medtronic Plc (Ireland)
  • Olympus (Japan)
  • Becton, Dickinson and Company (United States)
  • Boston Scientific Corporation (United States)
  • Cook Group Incorporated (United States)
  • Argon Medical Devices, Inc (United States)
  • INRAD Inc. (United States)
  • Somatex Medical Technologies (Germany)
  • Stryker Corporation (United States)
Additional players considered in the study are as follows:
Cardinal Health (United States) , Remington Medical (United States) , HAKKO CO.,LTD (Japan) , Merit Medical Systems (United States)
Select User Access Type

Key Highlights of Report


Dec 2023 247 Pages 82 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

"Emergence of Liquid Biopsy" is seen as one of major influencing trends for Biopsy Needle Market during projected period 2021-2027.
The Concentration Rate of Global Biopsy Needle market is highlighted using HHI Index.
United States Players will contribute the maximum growth of Global Biopsy Needle market throughout the predicted period.

Know More About Global Biopsy Needle Market Report?